Exam 4 Flashcards

1
Q

protein surfaces are mostly ___________ with _________ crevices (hydrophobic/hydrophilic)

A

hydrophilic, hydrophobic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

_______ (high/low) protein content in blood plasma

A

high

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

protein binding results in non-uniform distribution of a drug in the body and hence affects which pharmacokinetic parameter?

A

Vd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

the _______ (majority/minority) of drug molecules in plasma are bound to plasma proteins

A

majority

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

______ (free/bound) drug molecules are pharmacologically active and in equilibrium with other type of drug - free or bound

A

free

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

clinical labs report total plasma as the plasma drug concentration, what is the total plasma concentration equal to?

A

bound + unbound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

this type of drug cannot easily pass through membranes, has a restrictive distribution and elimination, therapeutically inactive

A

bound drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

this type of drug crosses cell membranes, has a larger distribution, therapeutically active

A

free/unbound drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

major protein component of plasma and ECF, acidic and basic drugs bind to this

A

albumin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

plasma protein that basic drugs bind to

A

AAGP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

plasma proteins that lipophilic drugs bind to

A

lipoproteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what percentage of plasma protein binding means low binding?

A

less than 50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what percentage of plasma protein binding means high binding?

A

greater than 80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what does fu mean?

A

fraction unbound drug in plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what does fut mean?

A

fraction unbound drug in tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what does fu equal (what’s the equation)?

A

[unbound]/[unbound]+[bound]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what does Vp mean?

A

plasma volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what does Vt mean?

A

tissue volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

fu is _____ (higher, lower, constant) as Cp increases for drugs bound to albumin

A

constant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

the number of albumin protein binding sites is _______ (greater/less) than the drug molecules available for binding

A

much greater than

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

at very ______ (high/low) Cp binding sites are saturated so fu increases as Cp increases

A

high

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

if the fu value is 0.01, what is the percent protein binding?

A

99%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

if the fu value is 0.9, what is the percent protein binding?

A

10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

highly bound drugs have a ________ (high/low) fu, and drugs with this fu have a _______ (high/low) Vd

A

low, low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

a greater Vd causes what change in Cp?

A

decrease in Cp because greater Vd means more moves into tissues so there is less drug in the plasma (decreased Cp)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

changes in fu imply changes in the unbound drug concentration in plasma which can enter tissues and exert a pharmacological or toxicological effect but it can also be eliminated by what?

A

glomerular filtration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

for drugs whose fu increases and are subject to _______ elimination, the increased unbound drug concentration is SOMETIMES cancelled out by the increase in elimination by GFT

A

restrictive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what is Ka?

A

affinity constant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

a ______ (high/low) Ka value means strongly bound drugs (decreased fu) so larger dose needed

A

high

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

drug affinity (Ka and fu) is altered in what disease state?

A

uremia (consequence of severe renal disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

any factor that alters protein binding becomes clinically important when a drug is _______ (highly/not highly) protein bound, when fu is _______ (greater than/less than) 0.1

A

highly, less than

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

_________ (increase/decrease) in albumin during hepatic failure, renal failure, burns, stress/trauma, pregnancy, decreased binding of phenytoin for example (decreased Cp)

A

decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

______ (increase/decrease) in AAGP during myocardial infarction, renal failure, arthritis, surgery, increase in Cp of quinidine for example

A

increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

_____ (increase/decrease) in tissue binding affinity in uremia, increased Cp of digoxin for example

A

decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

when 2 drugs compete for the same binding site, one drug kicks out the other drug

A

displacement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

these drugs achieve high concentrations in plasma and bind to albumin/AAGP, displace other drugs from tissue sites

A

displacers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

“non-synthetic” or “functionalization” reactions, introduce or uncover a hydrophilic functional group

A

phase I of biotransformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

“synthetic” or “conjugation” reactions, drug or drug metabolite is attached to endogenous water-soluble molecule

A

phase II of biotransformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

drug metabolite is eliminated from cell via transporters in cell membrane

A

phase III of biotransformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

the phases of biotransformation ______ (do/do not) imply sequence

A

do not

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

examples of this are oxidation, hydrolysis, reduction, and demethylation

A

phase I reactions

42
Q

ester hydrolysis, amidase, epoxide hydrolase are enzyme examples of which type of reaction?

A

hydrolysis, phase I

42
Q

CYP450 and FAD monooxygenase (FMO) are enzyme examples of which type of reaction?

A

oxidation, phase I

43
Q

CYP450 and Azo reductase are enzyme examples of which type of reaction?

A

reduction, phase I

44
Q

CYP450 only is an enzyme example of which type of reaction?

A

demethylation, phase I

45
Q

examples of this are glucuronidation, sulfonation, glutathione conjugation, and acetylation

A

phase II reactions

46
Q

UDP-glucuronosyltransferase (UGT) is an enzyme example of what type of reaction?

A

glucuronidation, phase II

47
Q

PAPS-sulfotransferase (SULT) is an enzyme example of what type of reaction?

A

sulfonation, phase II

48
Q

glutathione-S-transferase is an enzyme example of which type of reaction?

A

glutathione conjugation

49
Q

N-Acetyltransferase (NAT) is an enzyme example of which type of reaction?

A

acetylation, phase II

50
Q

multidrug resistance proteins (MRP), P-glycoprotein (P-gp or MDR1), and solute carrier transporters (OATP, OCT) are examples of this

A

phase III reactions

51
Q

chemical conversion of a drug into another chemical form (metabolite)

A

biotransformation/metabolism

52
Q

what is km?

A

first-order rate constant for metabolism

53
Q

what is ke?

A

excretion rate constant

54
Q

how do you determine ke?

A

unchanged (not metabolized) drug in the urine

55
Q

what is fe?

A

fraction of drug excreted

56
Q

how to find fraction of drug metabolized?

A

1-fe

57
Q

for a drug eliminated by kidneys and liver, how does fe change with renal failure? liver cirrhosis?

A

decrease, constant (because no effect of liver on kidney processes)

58
Q

for a drug eliminated by kidneys and liver, how does ke, km, and k change with renal failure? liver cirrhosis?

A

renal failure: ke decreases, km constant (because no effect of kidney on liver processes), k decreases
liver cirrhosis: ke constant (because no effect of liver on kidney processes), km decreases, k decreases

59
Q

for a drug eliminated by kidneys and liver, k is approximately equal to what in renal failure? how about in liver cirrhosis?

A

renal failure: k about equal to km
hepatic cirrhosis: k about equal to ke

60
Q

what does total clearance equal?

A

nonrenal clearance (Clnr) + renal clearance (Clr)

61
Q

what are some sites of drug metabolism outside the liver (extrahepatic metabolism)?

A

small intestine (CYP3A4, UGT), vascular smooth muscle (GST), skin (SULT), kidneys (CYP450)

62
Q

if Clnr is _________ (greater/less) than or equal to 1500 mL/min - the average hepatic blood flow - then drug is metabolized faster than the rate of hepatic blood flow, therefore extrahepatic metabolism is present, need to compare Clnr with HBF not Clr

A

greater

63
Q

first pass effect _____ (increases/reduces) drug bioavailability, _____ (less/more) [systemic drug], AUCIV is greater than AUCoral, for drugs given orally the absolute bioavailability is less than or equal to 1

A

reduces, less

64
Q

fraction of drug extracted by the liver

A

hepatic extraction ratio (ERH)

65
Q

a _____ (high/low) ERH implies poor bioavailability due to extensive first pass effect

A

high

66
Q

what value indicates a low ERH?

A

less than 0.3

67
Q

what value indicates a high ERH?

A

greater than 0.7

68
Q

factors that affect hepatic clearance

A

blood flow, intrinsic clearance, protein binding

69
Q

variable Q, varies due to diet, physical activity, drugs (beta blockers decrease this and ultimately decrease Clh)

A

blood flow

70
Q

what is F’?

A

reduced bioavailability (amount of drug systemically absorbed after liver extraction)

71
Q

for drugs with ______ (high/low) ER the rate of drug metabolism is almost as high as the blood flow perfusing the liver, influenced by alterations in blood flow - flow dependent - for example beta blockers decrease Q and Clh resulting in increased Cp

A

high

72
Q

for drugs with ______ (high/low) ER the rate of drug metabolism is lower, flow independent, influenced by changes to enzyme function (induction, inhibition)

A

low

73
Q

reflects the inherent activities of all the enzymes involved in a drug’s biotransformation/metabolism

A

intrinsic clearance (Clint)

74
Q

______ (high/low) ERH drugs are affected by Clint

A

low

75
Q

for high ER drugs what is the main determinant of Clh?

A

Q, blood flow

76
Q

for low ER drugs what is the main determinant of Clh?

A

Clint

77
Q

bile produced in hepatic cells and enters gallbladder, active process so saturable, drug and metabolite excretion in bile depends on molecular weight (MW) and polarity

A

biliary excretion

78
Q

drugs/metabolites with a molecular weight of greater than 500 are excreted primarily through ______ (bile/ urine/both)

A

bile

79
Q

drugs/metabolites with a molecular weight of 300-500 are excreted primarily through ______ (bile/urine/both)

A

both

80
Q

drugs/metabolites with a molecular weight less than 300 are excreted primarily through ______ (bile/urine/both)

A

urine

81
Q

reabsorption of drug into the blood, polar glucuronides hydrolyzed back to less polar parent drug, intestinal beta-glucuronidase, evidenced by a secondary peak, important in multiple dosing or large single doses because can lead to drug accumulation to toxic levels (leflunomide), examples of drugs that do this –> morphine, indomethacin, pregnenolone, sulindac

A

enterohepatic circulation

82
Q

which CYP450 has the most genetic variation?

A

CYP2D6

83
Q

______ (poor/ultra) metabolizers have a higher incidence of side effects/toxicity

A

poor

84
Q

______ (poor/ultra) metabolizers have a greater chance of therapeutic failure

A

ultra

85
Q

by affecting the absorption, metabolism, distribution, and elimination processes that a drug is subject to genetic polymorphisms can significantly change PK parameters, this may necessitate changing the dosage regimen which is constituted by what?

A

DL (loading dose, to enable Css to be quickly attained), DM (maintenance dose, to keep Css within therapeutic range), tau (to maintain Css and reduce fluctuation and accumulation)

86
Q

the relationship between the dose and the time course of drug concentration in body

A

pharmacokinetics

87
Q

the relationship between drug concentration at the site of action and the effects of the drug

A

pharmacodynamics

88
Q

is it possible to directly measure drug levels at the site of action?

A

no

89
Q

whe rapid equilibrium exists between plasma drug concentration and drug concentration at site of action the drug concentration in the _______ can be used in the modeling process

A

blood

90
Q

what does E represent?

A

intensity of the effect

91
Q

what does C represent?

A

the drug concentration at the site of action

92
Q

what does S represent?

A

the slope parameter that reflects the potency of the drug (greater slope greater potency)

93
Q

what does E0 represent?

A

the effect in the absence of drug or the baseline effect, blood pressure for example exists in the absence of drug

94
Q

what does Emax represent?

A

the maximum effect resulting from the drug (intrinsic activity)

95
Q

what does EC50 represent?

A

the drug concentration when the effect is 50% of the maximum effect (a measure of the drug potency)

96
Q

what does n represent?

A

the parameter affecting the shape of the curve, related to the number of drug molecules bound to the receptor (greater n means greater number of drug molecules bound to receptor)

97
Q

the PK model estimates drug concentration in ______ (central/peripheral) compartment

A

peripheral

98
Q

causes of this include drug concentration effect relationship changes with time, drug may produce an effect by an indirect mechanism (like anticoagulants), prodrugs can cause this, may result in a hysteresis loop

A

drug effect time profile may not relate to drug concentration time profile

99
Q

arrows represent a series of observations, at a given plasma [drug] the drug effect will be different depending on whether the [drug] is high or low, time-dependent pharmacological response

A

hysteresis loop

100
Q

used when there is a time delay between plasma [drug] and effect, hypothetical compartment that links PK and PD models, drug transfer from plasma to effect compartment does not affect PK of drug, drug transfer is first order, drug effect determined by [drug] in this

A

effect compartment

101
Q

_______ (increasing/decreasing) the dose prolongs the duration of effect and duration ____ (is/isn’t) proportional to administered dose

A

increasing, isn’t